- Home
- CNTX vs SEER Comparison
CNTX vs SEER Comparison
Compare CNTX & SEER Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | CNTX | SEER |
|---|---|---|
| Founded | 2015 | 2017 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Medicinal Chemicals and Botanical Products |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 116.7M | 98.2M |
| IPO Year | 2021 | 2020 |
Fundamental Metrics
Financial Performance| Metric | CNTX | SEER |
|---|---|---|
| Price | $1.54 | $1.82 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 8 | 0 |
| Target Price | ★ $5.67 | N/A |
| AVG Volume (30 Days) | ★ 730.1K | 199.3K |
| Earning Date | 11-05-2025 | 11-06-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $16,376,999.00 |
| Revenue This Year | N/A | $22.37 |
| Revenue Next Year | N/A | $30.00 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ 12.11 |
| 52 Week Low | $0.49 | $1.62 |
| 52 Week High | $1.55 | $2.50 |
Technical Indicators
Market Signals| Indicator | CNTX | SEER |
|---|---|---|
| Relative Strength Index (RSI) | 72.39 | 38.23 |
| Support Level | $1.09 | $1.80 |
| Resistance Level | $1.34 | $1.88 |
| Average True Range (ATR) | 0.13 | 0.07 |
| MACD | 0.04 | 0.01 |
| Stochastic Oscillator | 88.14 | 26.32 |
Price Performance
Historical ComparisonAbout CNTX Context Therapeutics Inc.
Context Therapeutics Inc is a clinical-stage biopharmaceutical company advancing medicines for solid tumors. The development team is advancing a pipeline of various therapies with a primary focus on treating female, hormone-dependent cancer, including breast, ovarian, and endometrial cancer. The company's preclinical program, CTIM-76, is an anti-Claudin 6 (CLDN6) x anti-CD3 bispecific antibody (bsAb) that is intended to redirect T-cell-mediated lysis toward malignant cells expressing CLDN6.
About SEER Seer Inc.
Seer Inc is a biotechnology company. The company commercializes transformative products for researchers to unlock deep, unbiased biological information. Its product, the Proteograph Product Suite (Proteograph), will leverage its proprietary engineered nanoparticle (NP) technology to provide unbiased, deep, rapid, and large-scale access across the proteome.